Across TCGA pan-cancer cohorts, BLOC1S5-TXNDC5 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated BLOC1S5-TXNDC5 data layer compared with 23 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher BLOC1S5-TXNDC5 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated BLOC1S5-TXNDC5 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.
KIRP, COAD, and UCEC are the cancer types where BLOC1S5-TXNDC5 Mutation most reproducibly stratifies survival.